LeMaitre Vascular (LMAT) PT Lowered to $46 at Roth Capital
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $79.29 +0.62%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Roth Capital analyst Scott R. Henry lowered the price target on LeMaitre Vascular (NASDAQ: LMAT) to $46.00 (from $50.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Ametek Inc. (AME) PT Raised to $290 at BNP Paribas Exane
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
